2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005
News and Resources
2010 Releases
11/08/2022 - Opexa Therapeutics Reports Third Quarter 2010 Financial Results
09/14/2010 - Letter to Shareholders
08/09/2022 - Opexa Therapeutics Reports Second Quarter 2010 Financial Results
08/05/2022 - Opexa Reconstitutes Scientific Advisory Board with Industry Leaders
06/07/2022 - Letter to Shareholders
06/03/2022 - Opexa to Prepay Convertible Notes Issued in 2009
05/13/2010 - Opexa Therapeutics Reports First Quarter 2010 Financial Results
05/11/2021 - Opexa Strengthens Tovaxin® Patent Estate Through Issuance of Key Patents
04/27/2010 - Opexa Strengthens Management Team with Hire of Cell Therapy Expert
04/14/2010 - Opexa Presents Tovaxin Data at the American Academy of Neurology 2010 Annual Meeting
04/06/2022 - Opexa to Present Tovaxin Data at the American Academy of Neurology 2010 Annual Meeting
03/05/2022 - Opexa Therapeutics Reports Year End 2009 Financial Results
02/03/2022 - Opexa to Present at the 12th Annual BIO CEO & Investor Conference on February 8, 2022